Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stromal cell therapy for severe COVID-19 infection
2020-002102-58Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Liège
- Start
- May 2020
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of Provacel in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoint: Safety co-primary endpoint. Started May 2020; status: completed.
02
Drugs
Provacel
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002102-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002102-58.